Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Nephropathy”

395 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 395 results

Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Large-scale testing (Phase 3)Study completedNCT05803421
What this trial is testing

Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Who this might be right for
Type 2 DiabetesObesityOverweight or Obesity+3 more
Eli Lilly and Company 2,749
Not applicableActive Not RecruitingNCT04960514
What this trial is testing

Prospective Decision Impact Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2+1 more
Renalytix AI, Inc. 2,000
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Post-approval studies (Phase 4)UnknownNCT00949351
What this trial is testing

Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

Who this might be right for
Type 2 Diabetes With Nephropathy
Lerdsin General Hospital 80
Large-scale testing (Phase 3)WithdrawnNCT03105219
What this trial is testing

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Who this might be right for
Diabetic Kidney Disease
Nanjing First Hospital, Nanjing Medical University
Testing effectiveness (Phase 2)Ended earlyNCT00157508
What this trial is testing

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Who this might be right for
Type 2 DiabetesEarly Nephropathy
Mario Negri Institute for Pharmacological Research 13
Post-approval studies (Phase 4)Study completedNCT03006952
What this trial is testing

Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy

Who this might be right for
Diabetic Nephropathies
Tehran University of Medical Sciences 59
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Post-approval studies (Phase 4)Study completedNCT00363987
What this trial is testing

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Who this might be right for
Diabetic Nephropathy
Fresenius Kabi 179
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT00811889
What this trial is testing

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesDiabetic Nephropathy
Biogen 227
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Not applicableUnknownNCT04411342
What this trial is testing

Normoalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Who this might be right for
Chronic Kidney Diseases
Assiut University 200
Early research (Phase 1)Study completedNCT01407276
What this trial is testing

Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Who this might be right for
Chronic Renal InsufficiencyType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 49
Large-scale testing (Phase 3)Study completedNCT04881123
What this trial is testing

SER150 vs Placebo in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Serodus AS 20
Next Page